February 25-27, 2018
The Westin Pune Koregaon Park, Pune, India
Dealing with Organic Impurities for effective life cycle management of chemical products
Tuesday, February 27th, 1:55 PM–2:20 PM Parallel session: Integrated Drug Development: Chemistry, Manufacturing and Control (CMC)
Session IV: Manufacturing
Abstract: Pharmaceutical or chemical industry has been producing one of the purest and safe chemical compounds for a long time, however they are highly regulated to ensure this keeps happening. All these companies are hence working/dealing with Impurities (and degradents) as a routine. In the recent past with increased focus on CMC business; it has become a centerpiece to turn around all projects quickly.
The reality is that, this task is not as easy as it sounds; they are required to work on it in detail; and generate all the necessary information involving several analytical and biological experiments. Organisations, be it pharmaceuticals or chemical, are spending a lot of time in ensuring the purity of a compound, though the formation of impurities is an inevitable part in this process. Additionally, in the current R&D landscape, it is mandatory for organisations to maintain the information of the origination, control and fate of all the impurities associated with the process of manufacturing. There is a need to captures all of that in an organized fashion and share from a collaborative interface. This presentation will outline how by taking small steps and making intelligent decisions you can take a big leap in your efficiency of dealing with impurities. This narration is about how with a systematic and unified approach at R&Ds we can enable identifying, characterizing and evaluating Impurities (& degradents). We will be sharing how the new technology can help in creating an impurity or product life cycle management system which will generate enough scientific justification and help control the impurities.
Want to learn more?Contact Us